Peoples Financial Services Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-36
| Closed | -$6K | – | 279 |
|
2022
Q1 | $6K | Hold |
36
| – | – | ﹤0.01% | 252 |
|
2021
Q4 | $5K | Hold |
36
| – | – | ﹤0.01% | 245 |
|
2021
Q3 | $5K | Hold |
36
| – | – | ﹤0.01% | 253 |
|
2021
Q2 | $6K | Hold |
36
| – | – | ﹤0.01% | 258 |
|
2021
Q1 | $6K | Hold |
36
| – | – | ﹤0.01% | 252 |
|
2020
Q4 | $6K | Hold |
36
| – | – | ﹤0.01% | 246 |
|
2020
Q3 | $5K | Hold |
36
| – | – | ﹤0.01% | 240 |
|
2020
Q2 | $4K | Hold |
36
| – | – | ﹤0.01% | 261 |
|
2020
Q1 | $4K | Hold |
36
| – | – | ﹤0.01% | 264 |
|
2019
Q4 | $5K | Hold |
36
| – | – | ﹤0.01% | 272 |
|
2019
Q3 | $5K | Hold |
36
| – | – | ﹤0.01% | 281 |
|
2019
Q2 | $5K | Hold |
36
| – | – | ﹤0.01% | 284 |
|
2019
Q1 | $5K | Hold |
36
| – | – | ﹤0.01% | 278 |
|
2018
Q4 | $4K | Hold |
36
| – | – | ﹤0.01% | 288 |
|
2018
Q3 | $6K | Hold |
36
| – | – | ﹤0.01% | 278 |
|
2018
Q2 | $6K | Hold |
36
| – | – | ﹤0.01% | 258 |
|
2018
Q1 | $5K | Hold |
36
| – | – | ﹤0.01% | 281 |
|
2017
Q4 | $5K | Hold |
36
| – | – | ﹤0.01% | 278 |
|
2017
Q3 | $5K | Hold |
36
| – | – | ﹤0.01% | 269 |
|
2017
Q2 | $6K | Hold |
36
| – | – | ﹤0.01% | 257 |
|
2017
Q1 | $5K | Hold |
36
| – | – | ﹤0.01% | 273 |
|
2016
Q4 | $5K | Hold |
36
| – | – | ﹤0.01% | 248 |
|
2016
Q3 | $4K | Hold |
36
| – | – | ﹤0.01% | 273 |
|
2016
Q2 | $5K | Hold |
36
| – | – | ﹤0.01% | 248 |
|
2016
Q1 | $5K | Hold |
36
| – | – | ﹤0.01% | 246 |
|
2015
Q4 | $5K | Hold |
36
| – | – | ﹤0.01% | 243 |
|
2015
Q3 | $5K | Hold |
36
| – | – | ﹤0.01% | 246 |
|
2015
Q2 | $6K | Hold |
36
| – | – | ﹤0.01% | 248 |
|
2015
Q1 | $6K | Hold |
36
| – | – | ﹤0.01% | 250 |
|
2014
Q4 | $6K | Hold |
36
| – | – | ﹤0.01% | 258 |
|
2014
Q3 | $6K | Hold |
36
| – | – | ﹤0.01% | 250 |
|
2014
Q2 | $5K | Hold |
36
| – | – | ﹤0.01% | 272 |
|
2014
Q1 | $5K | Hold |
36
| – | – | ﹤0.01% | 264 |
|
2013
Q4 | $5K | Buy |
+36
| New | +$5K | ﹤0.01% | 275 |
|